Results 141 to 150 of about 17,623 (223)

Interconnection between polycystic ovary syndrome, immune disorders, and reproductive outcomes. [PDF]

Reprod Fertil
Romero TB, de Sousa Sobral D, Aguiar LAA, Ponte HA, Romero Filho RE, Montenegro ALR, Maia MGR, Marques TG, de Oliveira Martins L, Cavalcante MB.   +9 more
europepmc   +1 more source

Modern Polycystic Ovary Syndrome (PCOS) Management: Intelligent Drug Delivery and Metabolic Reprogramming for Ovarian Restoration and Fertility Optimization. [PDF]

Biomolecules
Harrath AH, Jalouli M, Al-Zharani M, Rahman MA.   +3 more
europepmc   +1 more source

Ovarian Hyperandrogenism [PDF]

, 2020
openaire   +1 more source

Evaluation and management of worsening virilization in a postmenopausal woman diagnosed with PCOS. [PDF]

J Endocr Soc
Osborne MF, Horton WB, Pesch AJ, Santen RJ.   +3 more
europepmc   +1 more source

MeCP2 Governs maternal hyperandrogenism-induced cortical defects and behavioral alterations via noncanonical AR-dependent regulation of Mef2c. [PDF]

Nat Commun
Wang YM, Jia Y, Wu Y, Zhao Q, Guo Y, Zhang L, Jin M, Zheng Y.   +7 more
europepmc   +1 more source

What's in a name? From PCOS to polyendocrine metabolic ovarian syndrome: A metabolic reframing, promise, controversies, and challenges ahead. [PDF]

Metabol Open
Dalamaga M.
europepmc   +1 more source

Bridging the Practice Gap: Polycystic Ovary Syndrome as an Under-Recognised Risk State for Ischaemic Stroke and Cardiovascular Disease. [PDF]

J Clin Med
Jamshaid M, Sheikh AA, Jamshaid W, Shafiq H, Ahmed MH.   +4 more
europepmc   +1 more source

Dihydroartemisinin for the treatment of polycystic ovary syndrome: study protocol for a multi-centre placebo-controlled randomised clinical trial. [PDF]

BMJ Open
Mu L, Shen Y, Wang G, Liu C, Yang H, Li W, Mol BW, Li X, Dong X, Jiang J.   +9 more
europepmc   +1 more source